The Lundbeck Foundation launches 2030 strategy with ambitious goals for grant and commercial activities
December 22, 2020
With its strategy for 2030, “Bringing Discoveries to Lives”, the Lundbeck Foundation is embarking on a new chapter. A doubling of its wealth enables the Foundation to double its grants, with the aim of securing Denmark a top position among the world’s leading brain research nations.
‘Over the next ten years we will double our fixed grants for research in Denmark, develop a clearer, more strategic focus on the brain, broaden our portfolio of long-term ownerships in the field of healthcare and launch specific initiatives to stimulate collaboration between academia and the business sector,’ says Lene Skole, CEO of the Lundbeck Foundation.
The sharp focus on the brain and brain research is intrinsically linked to the astronomical cost of brain disorders to society. New research conducted at Aarhus University shows that brain disorders affect one in five Danes, and the direct and indirect costs associated with these disorders amount to more than DKK 100 billion a year. What’s more, the human cost paid by both patients and their relatives is immense.
The strategy applies to all of the Lundbeck Foundation’s activities. The aim is for the portfolio of long-term ownerships to grow to five to eight healthcare companies, and the ambition is that, with the Lundbeck Foundation as an engaged owner, these companies will develop into global leaders within their fields.
‘So, we help create new, foundation-owned companies in Denmark, we help Denmark bolster its leading position as a life science nation, and we pave the way for new and improved therapies as yet unavailable on the market,’ says Lene Skole.